Vyvanse cost without insurance 2026?

Short answer: in the U.S. in 2026, paying cash (no insurance) for Vyvanse typically runs about $400–$600 for a 30‑day supply (one bottle of 30 capsules). The exact price depends on the capsule strength (dose), pharmacy, and location. Higher doses tend to be more expensive.

What that means in practice
- A common starting point (30 mg, 30 capsules) is usually in the roughly $400–$500 range at many pharmacies.
- Stronger doses (e.g., 60–70 mg) can push costs higher, often approaching $550–$600 or more for a 30‑day supply.
- Prices vary a lot from one pharmacy to another, and discounts can make a big difference.

Ways to check and possibly lower out-of-pocket
- Check cash price at multiple pharmacies (CVS, Walgreens, Walmart, etc.) using the “cash price” option.
- Use discount programs: GoodRx, RxSaver, SingleCare often show lower cash prices and can be used at many pharmacies.
- Ask about a Vyvanse savings card or manufacturer programs on Takeda’s site (price assistance programs can sometimes reduce out-of-pocket).
- If cost is prohibitive, ask your prescriber about alternatives (e.g., other ADHD stimulants) or a different dosing strategy that might lower the monthly cost. Note: generic lisdexamfetamine is not widely available in the US, so the cash price is typically for brand-name Vyvanse.
- Consider long-term options like 90‑day mail‑order if your plan or a program offers it, which can lower the per‑month cost.

If you share your city/state and the exact dose you’re prescribed (for example, 30 mg or 70 mg, and how many capsules per month), I can give you a more specific estimate or look up current cash prices at nearby pharmacies.